# OnCo record nct07226856 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07226856/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07226856", "NCT07226856" ;
  schema:name "BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma"@en ;
  schema:description "A phase 2 trial of gemcitabine, nab-paclitaxel and nivolumab in pancreatic cancer, run by Mayo Clinic, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07226856/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07226856> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/nivolumab/> .